NCBiotech News

Peyton Howell of Paraxel International in Durham and Dave Oury of Medical Leverage in Cary were named to the PharmaVoice 100, an annual list that recognizes inspirational and innovative individuals who are making positive contributions to the life sciences

Metrics Contract Services, a full-service global contract development and manufacturing organization (CDMO) based in Greenville, has expanded its facilities for producing oral, solid-dose drugs.

A $441,028 grant from the National Science Foundation will help a group of educational institutions in the Piedmont Triad prepare a skilled workforce for jobs in regenerative medicine.

Six-year-old Marley enjoys playing with her toys and idolizes her older brother. However, it took a world of support, dozens of doctor’s visits, and a medical miracle that included Metabolon's precision diagnostics technology, to get here.

Tempus, a fast-growing artificial intelligence and precision medicine company, has established a new Durham lab, and plans to hire staff to fully occupy the 52,000-square foot site at 25 Parmer Way.

Global biopharmaceutical icon Amgen Inc. is building a $550 million manufacturing facility in Holly Springs that will employ 355 people

Bioventus, a global orthobiologics company headquartered in Durham, will acquire Misonix, a New York-based developer of ultrasonic surgical devices, in a cash-and-stock transaction valued at about $518 million.

The North Carolina Biotechnology Center awarded 21 grants and loans totaling more than $1.9 million to universities and biosciences companies and other entities in the fourth quarter of its fiscal year.

Seqirus, the global vaccine maker with a mega factory in Holly Springs, has just begun to ship its portfolio of seasonal flu vaccines to healthcare providers across the United States. It is prepared to supply approximately 60 million doses to meet demand for the 2021-2022 flu season.

Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a strategic alliance between the two companies.

NIEHS’s 24th annual Biomedical Career Symposium will be held virtually on Thursday and Friday, August 26 and 27.

If you're interested in a life sciences career, mark your calendar for Wednesday, August 4 when BioNetwork hosts its fifth virtual career fair in partnership with biopharmaceutical and life sciences companies from across the state.

Raleigh emerged as the No. 5 metro area in the latest Wall Street Journal/Realtor.com Emerging Housing Markets Index, while Burlington hit #19 and Durham-Chapel Hill ranked #22 among the nation's top 300 markets.

RTP regenerative health company Merakris Therapeutics is providing a new eye-care product to eye surgeons and their patients in the Carolinas and Texas, thanks to a partnership with Winston-Salem nonprofit Miracles in Sight.

North Carolina has one of the largest biopharma manufacturing industries in the nation, and a well-coordinated workforce development network is providing the right stuff to keep it growing.